v3.26.1
Consolidated statements of profit or loss - EUR (€)
€ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
CONTINUING OPERATIONS      
Revenue € 240,498 € 291,864 [1] € 386,976 [1]
Cost of sales (100,620) (119,368) [1] (146,576) [1]
Gross profit 139,878 172,496 [1] 240,400 [1]
Marketing and selling expenses (170,591) (206,942) [1] (224,850) [1]
General and administrative expenses (107,311) (109,007) [1] (129,182) [1]
Impairment of goodwill and brand (66,730) (31,208) [1]  
Other operating income and expenses (10,631) 7,896 [1] (4,549) [1]
Loss from operations before non-underlying items (215,385) (166,765) [1] (118,181) [1]
Non-underlying items (16,263) 10,243 [1] (3,781) [1]
Loss from operations (231,648) (156,522) [1] (121,962) [1]
Finance cost - net (35,490) (29,398) [1] (20,014) [1]
Loss before income tax (267,138) (185,920) [1] (141,976) [1]
Income tax benefits / (expenses) 15,775 (3,086) [1] (3,323) [1]
Loss from continuing operations (251,363) (189,006) [1] (145,299) [1]
DISCONTINUED OPERATIONS      
Loss from discontinued operations (11,982) (289) [1] (954) [1]
Loss from continuing operations (263,345) (189,295) [1] (146,253) [1]
Attributable to:      
- Owners of the Company (238,494) (165,255) [1] (129,313) [1]
- Continuing operations (226,512) (164,966) [1] (128,359) [1]
- Discontinued operations (11,982) (289) [1] (954) [1]
- Non-controlling interests € (24,851) € (24,040) [1] € (16,940) [1]
Loss per share in Euro      
Basic (in Euro per share) € (2.04) € (1.41) [1] € (0.98) [1]
- From continuing operations (in Euro per share) (1.93) (1.41) [1] (0.98) [1]
- From discontinued operations (in Euro per share) (0.11)    
Diluted (in Euro per share) (2.04) (1.41) (0.98)
- From continuing operations (in Euro per share) (1.93) € (1.41) € (0.98)
- From discontinued operations (in Euro per share) € (0.11)    
[1] In accordance with IFRS 5, the consolidated statements of profit or loss for 2024 and 2023 have been restated, with the Caruso Brand presented as a discontinued operation (see Note 12).